INBS
Intelligent Bio Solutions Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.23
−3.04%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-11.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 20, 2026 | Simeonidis Harry · officer: Chief Executive Officer | A-Award | 21,350 | $0.00 |
| Mar 20, 2026 | Fraser Nicola Marion · director | A-Award | 5,000 | $0.00 |
| Mar 20, 2026 | Sakiris Spiro Kevin · officer: Chief Financial Officer | A-Award | 9,150 | $0.00 |
| Mar 20, 2026 | Sakiris Spiro Kevin · officer: Chief Financial Officer | A-Award | 21,350 | $0.00 |
| Mar 20, 2026 | Hurd Jonathan Scott · director | A-Award | 5,000 | $0.00 |
| Mar 20, 2026 | Isenberg Jason · director | A-Award | 5,000 | $0.00 |
| Mar 20, 2026 | Simeonidis Harry · officer: Chief Executive Officer | A-Award | 9,150 | $0.00 |
| Mar 20, 2026 | Boyages Steven Constantine · director | A-Award | 5,000 | $0.00 |
| Sep 27, 2024 | Sakiris Spiro Kevin · officer: Chief Financial Officer | A-Award | 34,500 | $0.00 |
| Sep 27, 2024 | Simeonidis Harry · officer: Chief Executive Officer | A-Award | 40,000 | $0.00 |
| Oct 6, 2023 | TOWERS CHRISTOPHER · director | Purchase | 9,090 | $0.55 |
| Oct 6, 2023 | Sakiris Spiro Kevin · officer: Chief Financial Officer | Purchase | 112,727 | $0.55 |
| Sep 5, 2023 | Simeonidis Harry · officer: CEO | Purchase | 50 | $1.85 |
| Sep 5, 2023 | Simeonidis Harry · officer: CEO | Purchase | 100 | $1.92 |
Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 0Sold out 1
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Sold Out | 0 | Mar 25, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 20, 2026